Skip to content
  • Sunday, 26 July 2026
  • 2:58 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Scientists Develop High Potency Vitamin K Analogues to Drive Brain Cell Regeneration in Neurodegenerative Disease Research
Neuroscience & Brain Research

Scientists Develop High Potency Vitamin K Analogues to Drive Brain Cell Regeneration in Neurodegenerative Disease Research

Rifan Muazin Jun 3, 2026 0

The global medical community is currently witnessing a paradigm shift in the approach to treating neurodegenerative conditions such as Alzheimer’s,…

Read More
Neuroscience & Brain Research

Researchers Develop Novel Vitamin K Analogues as Potential Regenerative Therapy for Neurodegenerative Diseases

Rifan Muazin May 27, 2026 0

Researchers at the Shibaura Institute of Technology (SIT) in Japan have developed a novel vitamin K analogue that demonstrates significantly…

Read More
Messenger RNA’s Unsung Tail: New Discovery Reveals Critical Role in Protein Folding and Cellular RegulationJazz Pharmaceuticals and AbCellera Forge Strategic Alliance to Pioneer Novel T-cell Engaging Antibodies for Gastrointestinal and Solid TumorsTop Automated Dispensing Cabinets for Pharmacies: Leading Brands ComparedUCB Acquires Neurona Therapeutics for Up to $1.15 Billion to Bolster Epilepsy Pipeline with Regenerative Cell Therapy
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ